Breast Cancer Clinical Trial
Official title:
A Study of Breast Cancer, Breast Disease, Mammographic Density and Pesticides Among a Population From Triana, Alabama
This study will collect information on the height and weight of women who participated in a
1998 study in Triana, Alabama, on the risk of breast cancer and benign breast disease in
relation to environmental exposure to the pesticide DDT and similar chemicals. This
additional information is needed to calculate the participants' body mass index (BMI), which
is required for completing analysis of the data.
The 1998 study-a collaborative effort of the National Cancer Institute, the Triana Area
Medical Fund, and the College of Nursing at the University of Alabama at
Huntsville-investigated possible effects of DDT and other compounds on the risk of breast
cancer, predominantly among African-American women in the area of Triana, Alabama. The study
was initiated as a result of medical findings showing high blood levels of DDT among the
local population who had consumed fish from a tributary of the Tennessee River that had been
polluted by the discharge over several decades of large quantities of pesticides from a DDT
production plant.
Women participating in the study had a mammogram, physical examination, breast examination,
and blood draw, and completed a questionnaire on diet and lifestyle factors. In order to
complete analysis of the data and determine whether there is an association between
environmental exposure to DDT and related chemicals and breast cancer risk, additional
information on BMI is required.
A DDT production plant in Alabama discharged large quantities of the pesticide into the
tributaries of the Tennessee River for several decades before it was discovered in the
1970's. A survey found that local primarily African-American, populations consuming fish from
the river had accumulated body burdens of the chemical that were orders of magnitude above
the general population. The settlement of law suits involving 1000 named plaintiffs by the
Federal District Court in Birmingham, AL led to the development of the Triana Area Medical
Fun, Inc. This fund provides 'health care and monitoring' for named plaintiffs as well as
other residents of Triana who, as of August 1983, had not asked the Court for damages. The
Board managing the activities of the Fund has given approval for this project.
The National Cancer Institute, in collaboration with the Triana Area Medical Fund and the
College of Nursing at the University of Alabama in Huntsville, is conducting a study to
investigate the possible effects of environmental exposures, such as the pesticide DDT and
other organochlorines compounds, on the risk of breast cancer. Individuals covered by the
Triana Area Medical Fund and other nearby residents were asked to participate.
The objective is to evaluate the risk of breast cancer associated with organochlorines
exposures among predominatly African-American women. This project is comprised of two major
components (1) comparison of blood serum levels of DDT, DDE and other organochlorines
compounds among members of the Triana Area Medical Fund population with a high percentage of
mammographic densities to women without this condition and (2) methodologic investigations on
organochlorines retention/decay patterns within the well-characterized Triana Area Fund
population.
The investigators offered mammographic screening to all women within the cohort over the age
of 35 (about 350), as well as others who requested it. As a service to the participants, the
investigators provided a standard clinical chemistry on blood samples and made the results
available to the subject and their physician, if they so chose. If individuals did not have a
regular physician, they were assisted in locating one to provide consultation and
interpretation of examination results. Standard blood chemistries were performed locally in
Alabama. The remainder of the blood sample was processed and sent to NCI for analysis and
storage. Serum analyses were conducted by the National Center for Environmental Health at the
CDC.
Results of the mammography, clinical examination and blood chemistries were provided to the
participants in a manner agreeable to each. If the subject wished, the results were sent to
her private physician. They made arrangements with several local hospitals to provide
follow-up evaluation and therapy for women with breast diseases uncovered by mammography who
lacked health insurance. Nurse practitioners or physicians involved in the study were
available to discuss and explain results. For women who required additional diagnostic
evaluation or therapy, they developed a follow back procedure to make sure appropriate
actions are being taken.
Data collection is complete. Two hundred twenty eight women received mammograms, a physical
examination, provided a serum sample (50 ml) and completed a questionnaire on diet and
lifestyle factors. During the past year the investigators obtained information on height and
weight, which is necessary to calculate body mass indices. Analyses of the data are underway
and manuscripts are being developed.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A | |
Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A |